-
1
-
-
0019500566
-
Bleeding after liver biopsy does not correlate with indices of peripheral coagulation
-
7249879 10.1007/BF01313579 1:STN:280:DyaL3M3js1SktA%3D%3D
-
Ewe K. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 1981;26:388-393
-
(1981)
Dig Dis Sci
, vol.26
, pp. 388-393
-
-
Ewe, K.1
-
2
-
-
26944494224
-
Transfusion medicine/hemostasis clinical trials N. paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: An evidence-based review
-
16131373 10.1111/j.1537-2995.2005.00546.x
-
Segal JB, Dzik WH. Transfusion medicine/hemostasis clinical trials N. paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 2005;45:1413-1425
-
(2005)
Transfusion
, vol.45
, pp. 1413-1425
-
-
Segal, J.B.1
Dzik, W.H.2
-
3
-
-
5144222624
-
Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: A randomized, double-blind trial
-
15480990 10.1053/j.gastro.2004.07.015 1:CAS:528:DC%2BD2cXpsVOit78%3D
-
Bosch J, Thabut D, Bendtsen F, D'Amico G, Albillos A, Gonzalez Abraldes J, Fabricius S, et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 2004;127:1123-1130
-
(2004)
Gastroenterology
, vol.127
, pp. 1123-1130
-
-
Bosch, J.1
Thabut, D.2
Bendtsen, F.3
D'Amico, G.4
Albillos, A.5
Gonzalez Abraldes, J.6
Fabricius, S.7
-
4
-
-
23744438763
-
Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease
-
16035081 10.1002/lt.20458
-
Planinsic RM, van der Meer J, Testa G, Grande L, Candela A, Porte RJ, Ghobrial RM, et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl 2005;11:895-900
-
(2005)
Liver Transpl
, vol.11
, pp. 895-900
-
-
Planinsic, R.M.1
Van Der Meer, J.2
Testa, G.3
Grande, L.4
Candela, A.5
Porte, R.J.6
Ghobrial, R.M.7
-
5
-
-
60749116711
-
Risk of venous thromboembolism in patients with liver disease: A nationwide population-based case-control study
-
19098856 10.1038/ajg.2008.34
-
Sogaard KK, Horvath-Puho E, Gronbaek H, Jepsen P, Vilstrup H, Sorensen HT. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol 2009;104:96-101
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 96-101
-
-
Sogaard, K.K.1
Horvath-Puho, E.2
Gronbaek, H.3
Jepsen, P.4
Vilstrup, H.5
Sorensen, H.T.6
-
6
-
-
1942471058
-
Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis
-
15094219 10.1016/j.jhep.2004.01.001
-
Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, Grandone E, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004;40:736-741
-
(2004)
J Hepatol
, vol.40
, pp. 736-741
-
-
Amitrano, L.1
Guardascione, M.A.2
Brancaccio, V.3
Margaglione, M.4
Manguso, F.5
Iannaccone, L.6
Grandone, E.7
-
7
-
-
70649100102
-
An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis
-
19706293 10.1053/j.gastro.2009.08.045 1:CAS:528:DC%2BD1MXhs1Sisr3I
-
Tripodi A, Primignani M, Chantarangkul V, Dell'Era A, Clerici M, de Franchis R, Colombo M, et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 2009;137:2105-2111
-
(2009)
Gastroenterology
, vol.137
, pp. 2105-2111
-
-
Tripodi, A.1
Primignani, M.2
Chantarangkul, V.3
Dell'Era, A.4
Clerici, M.5
De Franchis, R.6
Colombo, M.7
-
8
-
-
33745875950
-
Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity
-
16799972 10.1002/hep.21231 1:CAS:528:DC%2BD28XnsFWjt7w%3D
-
Lisman T, Bongers TN, Adelmeijer J, Janssen HL, de Maat MP, de Groot PG, Leebeek FW. Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 2006;44:53-61
-
(2006)
Hepatology
, vol.44
, pp. 53-61
-
-
Lisman, T.1
Bongers, T.N.2
Adelmeijer, J.3
Janssen, H.L.4
De Maat, M.P.5
De Groot, P.G.6
Leebeek, F.W.7
-
9
-
-
70349194473
-
Acquired coagulation disorders: Revisited using global coagulation/anticoagulation testing
-
19659548 10.1111/j.1365-2141.2009.07833.x
-
Tripodi A, Chantarangkul V, Mannucci PM. Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing. Br J Haematol 2009;147:77-82
-
(2009)
Br J Haematol
, vol.147
, pp. 77-82
-
-
Tripodi, A.1
Chantarangkul, V.2
Mannucci, P.M.3
-
10
-
-
77954235112
-
Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method
-
20578143 10.1002/hep.23653 1:CAS:528:DC%2BC3cXpsFShtLY%3D
-
Tripodi A, Primignani M, Lemma L, Chantarangkul V, Dell'Era A, Iannuzzi F, Aghemo A, et al. Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method. Hepatology 2010;52:249-255
-
(2010)
Hepatology
, vol.52
, pp. 249-255
-
-
Tripodi, A.1
Primignani, M.2
Lemma, L.3
Chantarangkul, V.4
Dell'Era, A.5
Iannuzzi, F.6
Aghemo, A.7
-
11
-
-
33747058510
-
Thrombin generation in patients with cirrhosis: The role of platelets
-
16871542 10.1002/hep.21266 1:CAS:528:DC%2BD28XptVKmtLg%3D
-
Tripodi A, Primignani M, Chantarangkul V, Clerici M, Dell'Era A, Fabris F, Salerno F, et al. Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology 2006;44:440-445
-
(2006)
Hepatology
, vol.44
, pp. 440-445
-
-
Tripodi, A.1
Primignani, M.2
Chantarangkul, V.3
Clerici, M.4
Dell'Era, A.5
Fabris, F.6
Salerno, F.7
-
12
-
-
14244256300
-
Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests
-
15726661 10.1002/hep.20569 1:CAS:528:DC%2BD2MXisFCrsrY%3D
-
Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, Mannuccio Mannucci P. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005;41:553-558
-
(2005)
Hepatology
, vol.41
, pp. 553-558
-
-
Tripodi, A.1
Salerno, F.2
Chantarangkul, V.3
Clerici, M.4
Cazzaniga, M.5
Primignani, M.6
Mannuccio Mannucci, P.7
-
13
-
-
77956456135
-
Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy
-
20546119 10.1111/j.1538-7836.2010.03937.x 1:CAS:528:DC%2BC3cXht1yrtr7I
-
Gatt A, Riddell A, Calvaruso V, Tuddenham EG, Makris M, Burroughs AK. Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost 2010;8:1994-2000
-
(2010)
J Thromb Haemost
, vol.8
, pp. 1994-2000
-
-
Gatt, A.1
Riddell, A.2
Calvaruso, V.3
Tuddenham, E.G.4
Makris, M.5
Burroughs, A.K.6
-
14
-
-
77956267515
-
Revising consensus in portal hypertension: Report of the Baveno v consensus workshop on methodology of diagnosis and therapy in portal hypertension
-
20638742 10.1016/j.jhep.2010.06.004
-
de Franchis R, Baveno VF. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53:762-768
-
(2010)
J Hepatol
, vol.53
, pp. 762-768
-
-
De Franchis, R.1
Baveno, V.F.2
-
15
-
-
68249099452
-
Etiology, management, and outcome of the Budd-Chiari syndrome
-
19652186 10.7326/0003-4819-151-3-200908040-00004
-
Darwish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 2009;151:167-175
-
(2009)
Ann Intern Med
, vol.151
, pp. 167-175
-
-
Darwish Murad, S.1
Plessier, A.2
Hernandez-Guerra, M.3
Fabris, F.4
Eapen, C.E.5
Bahr, M.J.6
Trebicka, J.7
-
16
-
-
66149155797
-
Vascular disorders of the liver
-
American Association for the Study Liver D 19399912 10.1002/hep.22772 1:CAS:528:DC%2BD1MXlslKlsro%3D
-
DeLeve LD, Valla DC, Garcia-Tsao G, American Association for the Study Liver D. Vascular disorders of the liver. Hepatology 2009;49:1729-1764
-
(2009)
Hepatology
, vol.49
, pp. 1729-1764
-
-
Deleve, L.D.1
Valla, D.C.2
Garcia-Tsao, G.3
-
17
-
-
84856442866
-
Management of hepatic vascular diseases
-
22300463 10.1016/S0168-8278(12)60004-X 1:CAS:528:DC%2BC38XitVers70%3D
-
Plessier A, Rautou PE, Valla DC. Management of hepatic vascular diseases. J Hepatol 2012;56(Suppl 1):S25-38
-
(2012)
J Hepatol
, vol.56
, Issue.SUPPL. 1
-
-
Plessier, A.1
Rautou, P.E.2
Valla, D.C.3
-
18
-
-
0033002971
-
Outcome of Budd-Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shunting
-
10385643 10.1002/hep.510300125 1:STN:280:DyaK1MzhsFOnsw%3D%3D
-
Zeitoun G, Escolano S, Hadengue A, Azar N, El Younsi M, Mallet A, Boudet MJ, et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 1999;30:84-89
-
(1999)
Hepatology
, vol.30
, pp. 84-89
-
-
Zeitoun, G.1
Escolano, S.2
Hadengue, A.3
Azar, N.4
El Younsi, M.5
Mallet, A.6
Boudet, M.J.7
-
19
-
-
12444331970
-
Clinicopathological forms and prognostic index in Budd-Chiari syndrome
-
12971957 10.1016/S0168-8278(03)00323-4
-
Langlet P, Escolano S, Valla D, Coste-Zeitoun D, Denie C, Mallet A, Levy VG, et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol 2003;39:496-501
-
(2003)
J Hepatol
, vol.39
, pp. 496-501
-
-
Langlet, P.1
Escolano, S.2
Valla, D.3
Coste-Zeitoun, D.4
Denie, C.5
Mallet, A.6
Levy, V.G.7
-
20
-
-
10744232260
-
Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome
-
14768004 10.1002/hep.20064
-
Darwish Murad S, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, van Hoek B, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 2004;39:500-508
-
(2004)
Hepatology
, vol.39
, pp. 500-508
-
-
Darwish Murad, S.1
Valla, D.C.2
De Groen, P.C.3
Zeitoun, G.4
Hopmans, J.A.5
Haagsma, E.B.6
Van Hoek, B.7
-
21
-
-
33751002644
-
Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome
-
17058215 10.1002/hep.21354
-
Plessier A, Sibert A, Consigny Y, Hakime A, Zappa M, Denninger MH, Condat B, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006;44:1308-1316
-
(2006)
Hepatology
, vol.44
, pp. 1308-1316
-
-
Plessier, A.1
Sibert, A.2
Consigny, Y.3
Hakime, A.4
Zappa, M.5
Denninger, M.H.6
Condat, B.7
-
22
-
-
84879837006
-
Budd-chiari syndrome (BCS) and heparin induced thrombocytopenia (HIT)
-
Plessier ACY, Boudaoud L. Budd-chiari syndrome (BCS) and heparin induced thrombocytopenia (HIT). J Hepatol 2006;44
-
(2006)
J Hepatol
, pp. 44
-
-
Acy, P.1
Boudaoud, L.2
-
23
-
-
75649116507
-
Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis
-
20134155 10.1159/000280466 1:CAS:528:DC%2BC3cXktVyhsr8%3D
-
Randi ML, Tezza F, Scapin M, Duner E, Scarparo P, Scandellari R, Fabris F. Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis. Acta Haematol 2010;123:140-5
-
(2010)
Acta Haematol
, vol.123
, pp. 140-145
-
-
Randi, M.L.1
Tezza, F.2
Scapin, M.3
Duner, E.4
Scarparo, P.5
Scandellari, R.6
Fabris, F.7
-
24
-
-
57049177781
-
High incidence of heparin induced thrombocytopenia (HIT) in splanchnic vein thrombosis treated with low molecular weight heparin (LMWH)
-
Mea Primignani. High incidence of heparin induced thrombocytopenia (HIT) in splanchnic vein thrombosis treated with low molecular weight heparin (LMWH). J Hepatol 2008;48:S113
-
(2008)
J Hepatol
, vol.48
, pp. 113
-
-
Mea, P.1
-
25
-
-
78649634048
-
Bleeding in patients with Budd-Chiari syndrome
-
20889223 10.1016/j.jhep.2010.06.019
-
Rautou PE, Douarin L, Denninger MH, Escolano S, Lebrec D, Moreau R, Vidaud M, et al. Bleeding in patients with Budd-Chiari syndrome. J Hepatol 2011;54:56-63
-
(2011)
J Hepatol
, vol.54
, pp. 56-63
-
-
Rautou, P.E.1
Douarin, L.2
Denninger, M.H.3
Escolano, S.4
Lebrec, D.5
Moreau, R.6
Vidaud, M.7
-
26
-
-
0346689988
-
Pharmacological thrombolysis in Budd Chiari syndrome: A single centre experience and review of the literature
-
14672630 10.1016/j.jhep.2003.09.028 1:CAS:528:DC%2BD3sXps1Ogtrw%3D
-
Sharma S, Texeira A, Texeira P, Elias E, Wilde J, Olliff SP. Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature. J Hepatol 2004;40:172-180
-
(2004)
J Hepatol
, vol.40
, pp. 172-180
-
-
Sharma, S.1
Texeira, A.2
Texeira, P.3
Elias, E.4
Wilde, J.5
Olliff, S.P.6
-
27
-
-
57349200431
-
Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis
-
19132234 1:CAS:528:DC%2BD1MXptVyhtg%3D%3D
-
Smalberg JH, Spaander MV, Jie KS, Pattynama PM, van Buuren HR, van den Berg B, Janssen HL, et al. Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis. Thromb Haemost 2008;100:1084-1088
-
(2008)
Thromb Haemost
, vol.100
, pp. 1084-1088
-
-
Smalberg, J.H.1
Spaander, M.V.2
Jie, K.S.3
Pattynama, P.M.4
Van Buuren, H.R.5
Van Den Berg, B.6
Janssen, H.L.7
-
28
-
-
33646441796
-
Portal vein thrombosis: Prevalence, patient characteristics and lifetime risk: A population study based on 23,796 consecutive autopsies
-
16610067
-
Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 2006;12:2115-2119
-
(2006)
World J Gastroenterol
, vol.12
, pp. 2115-2119
-
-
Ogren, M.1
Bergqvist, D.2
Bjorck, M.3
Acosta, S.4
Eriksson, H.5
Sternby, N.H.6
-
29
-
-
0033840182
-
Recent portal or mesenteric venous thrombosis: Increased recognition and frequent recanalization on anticoagulant therapy
-
10960436 10.1053/jhep.2000.16597 1:STN:280:DC%2BD3cvislymug%3D%3D
-
Condat B, Pessione F, Helene Denninger M, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 2000;32:466-470
-
(2000)
Hepatology
, vol.32
, pp. 466-470
-
-
Condat, B.1
Pessione, F.2
Helene Denninger, M.3
Hillaire, S.4
Valla, D.5
-
30
-
-
73449145980
-
Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow-up study
-
19821530 10.1002/hep.23259
-
Plessier A, Darwish-Murad S, Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, Heller J, et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 2010;51:210-218
-
(2010)
Hepatology
, vol.51
, pp. 210-218
-
-
Plessier, A.1
Darwish-Murad, S.2
Hernandez-Guerra, M.3
Consigny, Y.4
Fabris, F.5
Trebicka, J.6
Heller, J.7
-
31
-
-
18444367119
-
Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis
-
15872320 10.1097/01.RVI.0000156265.79960.86
-
Hollingshead M, Burke CT, Mauro MA, Weeks SM, Dixon RG, Jaques PF. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol 2005;16:651-661
-
(2005)
J Vasc Interv Radiol
, vol.16
, pp. 651-661
-
-
Hollingshead, M.1
Burke, C.T.2
Mauro, M.A.3
Weeks, S.M.4
Dixon, R.G.5
Jaques, P.F.6
-
32
-
-
0345392724
-
Thrombolytic treatment of portal thrombosis
-
14696472
-
Malkowski P, Pawlak J, Michalowicz B, Szczerban J, Wroblewski T, Leowska E, Krawczyk M. Thrombolytic treatment of portal thrombosis. Hepatogastroenterology 2003;50:2098-2100
-
(2003)
Hepatogastroenterology
, vol.50
, pp. 2098-2100
-
-
Malkowski, P.1
Pawlak, J.2
Michalowicz, B.3
Szczerban, J.4
Wroblewski, T.5
Leowska, E.6
Krawczyk, M.7
-
33
-
-
35448981059
-
Prognostic factors in noncirrhotic patients with splanchnic vein thromboses
-
17958760 10.1111/j.1572-0241.2007.01477.x
-
Amitrano L, Guardascione MA, Scaglione M, Pezzullo L, Sangiuliano N, Armellino MF, Manguso F, et al. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol 2007;102:2464-2470
-
(2007)
Am J Gastroenterol
, vol.102
, pp. 2464-2470
-
-
Amitrano, L.1
Guardascione, M.A.2
Scaglione, M.3
Pezzullo, L.4
Sangiuliano, N.5
Armellino, M.F.6
Manguso, F.7
-
34
-
-
0035121502
-
Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy
-
11159889 10.1053/gast.2001.21209 1:STN:280:DC%2BD3M7otVKnsw%3D%3D
-
Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC, Poliquin M, Hadengue A, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 2001;120:490-497
-
(2001)
Gastroenterology
, vol.120
, pp. 490-497
-
-
Condat, B.1
Pessione, F.2
Hillaire, S.3
Denninger, M.H.4
Guillin, M.C.5
Poliquin, M.6
Hadengue, A.7
-
35
-
-
33845529496
-
High incidence of concomitant venous thromboembolism in patients with portal vein thrombosis: A population study based on 23,796 consecutive autopsies
-
17059416 10.1111/j.1538-7836.2006.02264.x 1:STN:280: DC%2BD2s%2Fjs1CrsA%3D%3D
-
Ogren M, Bergqvist D, Bjorck M, Acosta S, Sternby NH. High incidence of concomitant venous thromboembolism in patients with portal vein thrombosis: a population study based on 23,796 consecutive autopsies. J Thromb Haemost 2007;5:198-200
-
(2007)
J Thromb Haemost
, vol.5
, pp. 198-200
-
-
Ogren, M.1
Bergqvist, D.2
Bjorck, M.3
Acosta, S.4
Sternby, N.H.5
-
36
-
-
33846188112
-
Chronic mesenteric venous thrombosis: Evaluation and determinants of survival during long-term follow-up
-
17142105 10.1016/j.cgh.2006.09.030 1:CAS:528:DC%2BD2sXitVCmsbo%3D
-
Orr DW, Harrison PM, Devlin J, Karani JB, Kane PA, Heaton ND, O'Grady JG, et al. Chronic mesenteric venous thrombosis: evaluation and determinants of survival during long-term follow-up. Clin Gastroenterol Hepatol 2007;5:80-86
-
(2007)
Clin Gastroenterol Hepatol
, vol.5
, pp. 80-86
-
-
Orr, D.W.1
Harrison, P.M.2
Devlin, J.3
Karani, J.B.4
Kane, P.A.5
Heaton, N.D.6
O'Grady, J.G.7
-
37
-
-
69949162791
-
Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development
-
19464747 10.1016/j.jhep.2009.03.013
-
Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, Riccardi L, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009;51:682-689
-
(2009)
J Hepatol
, vol.51
, pp. 682-689
-
-
Zocco, M.A.1
Di Stasio, E.2
De Cristofaro, R.3
Novi, M.4
Ainora, M.E.5
Ponziani, F.6
Riccardi, L.7
-
38
-
-
20244371160
-
Splanchnic vein thrombosis in candidates for liver transplantation: Usefulness of screening and anticoagulation
-
15831918 10.1136/gut.2004.042796 1:STN:280:DC%2BD2M3isVSktA%3D%3D
-
Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, Denninger MH, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005;54:691-697
-
(2005)
Gut
, vol.54
, pp. 691-697
-
-
Francoz, C.1
Belghiti, J.2
Vilgrain, V.3
Sommacale, D.4
Paradis, V.5
Condat, B.6
Denninger, M.H.7
-
39
-
-
0026451673
-
The incidence of portal vein thrombosis at liver transplantation
-
1427658 10.1002/hep.1840160515 1:STN:280:DyaK3s%2Flt1Srsw%3D%3D
-
Nonami T, Yokoyama I, Iwatsuki S, Starzl TE. The incidence of portal vein thrombosis at liver transplantation. Hepatology 1992;16:1195-1198
-
(1992)
Hepatology
, vol.16
, pp. 1195-1198
-
-
Nonami, T.1
Yokoyama, I.2
Iwatsuki, S.3
Starzl, T.E.4
-
40
-
-
0033967582
-
Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis
-
10655256 10.1002/hep.510310213 1:CAS:528:DC%2BD3cXht1artLs%3D
-
Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Iannaccone L, D'Andrea G, Marmo R, et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 2000;31:345-348
-
(2000)
Hepatology
, vol.31
, pp. 345-348
-
-
Amitrano, L.1
Brancaccio, V.2
Guardascione, M.A.3
Margaglione, M.4
Iannaccone, L.5
D'Andrea, G.6
Marmo, R.7
-
41
-
-
77953762848
-
Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis
-
19730112 1:CAS:528:DC%2BC3cXns1yltrc%3D
-
Amitrano L, Guardascione MA, Menchise A, Martino R, Scaglione M, Giovine S, Romano L, et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol 2010;44:448-451
-
(2010)
J Clin Gastroenterol
, vol.44
, pp. 448-451
-
-
Amitrano, L.1
Guardascione, M.A.2
Menchise, A.3
Martino, R.4
Scaglione, M.5
Giovine, S.6
Romano, L.7
-
42
-
-
84862682514
-
Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis
-
22289875 10.1016/j.cgh.2012.01.012
-
Delgado MG, Seijo S, Yepes I, Achecar L, Catalina MV, Garcia-Criado A, Abraldes JG, et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol 2012;10:776-783
-
(2012)
Clin Gastroenterol Hepatol
, vol.10
, pp. 776-783
-
-
Delgado, M.G.1
Seijo, S.2
Yepes, I.3
Achecar, L.4
Catalina, M.V.5
Garcia-Criado, A.6
Abraldes, J.G.7
-
43
-
-
84861970773
-
Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis
-
22435854 10.1111/j.1478-3231.2012.02785.x 1:CAS:528:DC%2BC38Xht1SltrrF
-
Senzolo M, MS T, Rossetto V, Burra P, Cillo U, Boccagni P, Gasparini D. Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int 2012;32:919-927
-
(2012)
Liver Int
, vol.32
, pp. 919-927
-
-
Senzolo, M.1
Ms, T.2
Rossetto, V.3
Burra, P.4
Cillo, U.5
Boccagni, P.6
Gasparini, D.7
-
45
-
-
84861202740
-
Idiopathic noncirrhotic portal hypertension is associated with poor survival: Results of a long-term cohort study
-
22536808 10.1111/j.1365-2036.2012.05112.x 1:STN:280: DC%2BC38rotlChsg%3D%3D
-
Schouten JN, Nevens F, Hansen B, Laleman W, van den Born M, Komuta M, Roskams T, et al. Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study. Aliment Pharmacol Ther 2012;35:1424-1433
-
(2012)
Aliment Pharmacol Ther
, vol.35
, pp. 1424-1433
-
-
Schouten, J.N.1
Nevens, F.2
Hansen, B.3
Laleman, W.4
Van Den Born, M.5
Komuta, M.6
Roskams, T.7
-
46
-
-
0036073529
-
Idiopathic noncirrhotic intrahepatic portal hypertension in the West: A re-evaluation in 28 patients
-
12117894 10.1136/gut.51.2.275 1:STN:280:DC%2BD38zpslSksg%3D%3D
-
Hillaire S, Bonte E, Denninger MH, Casadevall N, Cadranel JF, Lebrec D, Valla D, et al. Idiopathic noncirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 2002;51:275-280
-
(2002)
Gut
, vol.51
, pp. 275-280
-
-
Hillaire, S.1
Bonte, E.2
Denninger, M.H.3
Casadevall, N.4
Cadranel, J.F.5
Lebrec, D.6
Valla, D.7
-
47
-
-
84878588537
-
Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension
-
22971050 10.1111/apt.12021 1:CAS:528:DC%2BC3sXjtVOksA%3D%3D
-
Schouten JN, Van der Ende ME, Koeter T, Rossing HH, Komuta M, Verheij J, van der Valk M, et al. Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension. Aliment Pharmacol Ther 2012;36:875-885
-
(2012)
Aliment Pharmacol Ther
, vol.36
, pp. 875-885
-
-
Schouten, J.N.1
Van Der Ende, M.E.2
Koeter, T.3
Rossing, H.H.4
Komuta, M.5
Verheij, J.6
Van Der Valk, M.7
-
48
-
-
67650450829
-
Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy
-
19471257 10.1038/ajg.2009.165 1:CAS:528:DC%2BD1MXotVKjurc%3D
-
Chang PE, Miquel R, Blanco JL, Laguno M, Bruguera M, Abraldes JG, Bosch J, et al. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy. Am J Gastroenterol 2009;104:1707-1714
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 1707-1714
-
-
Chang, P.E.1
Miquel, R.2
Blanco, J.L.3
Laguno, M.4
Bruguera, M.5
Abraldes, J.G.6
Bosch, J.7
-
49
-
-
42249108660
-
Thrombosis and anticoagulation in liver disease
-
18318436 10.1002/hep.22192 1:CAS:528:DC%2BD1cXkslOjsLk%3D
-
Valla DC. Thrombosis and anticoagulation in liver disease. Hepatology 2008;47:1384-1393
-
(2008)
Hepatology
, vol.47
, pp. 1384-1393
-
-
Valla, D.C.1
-
50
-
-
79951674881
-
Obliterative portal venopathy: Portal hypertension is not always present at diagnosis
-
21087805 10.1016/j.jhep.2010.07.038
-
Cazals-Hatem D, Hillaire S, Rudler M, Plessier A, Paradis V, Condat B, Francoz C, et al. Obliterative portal venopathy: portal hypertension is not always present at diagnosis. J Hepatol 2011;54:455-461
-
(2011)
J Hepatol
, vol.54
, pp. 455-461
-
-
Cazals-Hatem, D.1
Hillaire, S.2
Rudler, M.3
Plessier, A.4
Paradis, V.5
Condat, B.6
Francoz, C.7
-
51
-
-
33645216515
-
Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: A systematic review and meta-analysis
-
16489362 10.1038/sj.bmt.1705297 1:STN:280:DC%2BD287mt1elsw%3D%3D
-
Imran H, Tleyjeh IM, Zirakzadeh A, Rodriguez V, Khan SP. Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis. Bone Marrow Transpl 2006;37:677-686
-
(2006)
Bone Marrow Transplant
, vol.37
, pp. 677-686
-
-
Imran, H.1
Tleyjeh, I.M.2
Zirakzadeh, A.3
Rodriguez, V.4
Khan, S.P.5
-
52
-
-
1942456498
-
Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation
-
15111934 10.1016/j.bbmt.2004.01.002 1:CAS:528:DC%2BD2cXltVGis7c%3D
-
Chalandon Y, Roosnek E, Mermillod B, Newton A, Ozsahin H, Wacker P, Helg C, et al. Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Biol Blood Marrow Transpl 2004;10:347-354
-
(2004)
Biol Blood Marrow Transplant
, vol.10
, pp. 347-354
-
-
Chalandon, Y.1
Roosnek, E.2
Mermillod, B.3
Newton, A.4
Ozsahin, H.5
Wacker, P.6
Helg, C.7
-
53
-
-
20244365292
-
Defibrotide for the treatment of hepatic veno-occlusive disease: Results of the European compassionate-use study
-
11167751 10.1046/j.1365-2141.2000.02475.x 1:CAS:528:DC%2BD3MXhtVaku78%3D
-
Chopra R, Eaton JD, Grassi A, Potter M, Shaw B, Salat C, Neumeister P, et al. Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. Br J Haematol 2000;111:1122-1129
-
(2000)
Br J Haematol
, vol.111
, pp. 1122-1129
-
-
Chopra, R.1
Eaton, J.D.2
Grassi, A.3
Potter, M.4
Shaw, B.5
Salat, C.6
Neumeister, P.7
-
54
-
-
0032147122
-
Treatment of severe veno-occlusive disease with defibrotide: Compassionate use results in response without significant toxicity in a high-risk population
-
9680339 1:CAS:528:DyaK1cXltVOrsrg%3D
-
Richardson PG, Elias AD, Krishnan A, Wheeler C, Nath R, Hoppensteadt D, Kinchla NM, et al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood 1998;92:737-744
-
(1998)
Blood
, vol.92
, pp. 737-744
-
-
Richardson, P.G.1
Elias, A.D.2
Krishnan, A.3
Wheeler, C.4
Nath, R.5
Hoppensteadt, D.6
Kinchla, N.M.7
-
55
-
-
0037114746
-
Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: Response without significant toxicity in a high-risk population and factors predictive of outcome
-
12393437 10.1182/blood-2002-04-1216 1:CAS:528:DC%2BD38XpsFCqs7s%3D
-
Richardson PG, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D, Elias AD, et al. Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood 2002;100:4337-4343
-
(2002)
Blood
, vol.100
, pp. 4337-4343
-
-
Richardson, P.G.1
Murakami, C.2
Jin, Z.3
Warren, D.4
Momtaz, P.5
Hoppensteadt, D.6
Elias, A.D.7
-
56
-
-
0029075551
-
Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis)
-
7737628 1:STN:280:DyaK2M3lsFOqsg%3D%3D
-
Wanless IR, Liu JJ, Butany J. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology 1995;21:1232-1237
-
(1995)
Hepatology
, vol.21
, pp. 1232-1237
-
-
Wanless, I.R.1
Liu, J.J.2
Butany, J.3
-
57
-
-
80052546341
-
The role of hypercoagulability in liver fibrogenesis
-
21570930 10.1016/j.clinre.2011.03.011 1:CAS:528:DC%2BC3MXhtFKnt7rI
-
Anstee QM, Dhar A, Thursz MR. The role of hypercoagulability in liver fibrogenesis. Clin Res Hepatol Gastroenterol 2011;35:526-533
-
(2011)
Clin Res Hepatol Gastroenterol
, vol.35
, pp. 526-533
-
-
Anstee, Q.M.1
Dhar, A.2
Thursz, M.R.3
-
58
-
-
1242314392
-
PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation
-
14767989 10.1002/hep.20054 1:CAS:528:DC%2BD2cXjtlaitL4%3D
-
Fiorucci S, Antonelli E, Distrutti E, Severino B, Fiorentina R, Baldoni M, Caliendo G, et al. PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation. Hepatology 2004;39:365-375
-
(2004)
Hepatology
, vol.39
, pp. 365-375
-
-
Fiorucci, S.1
Antonelli, E.2
Distrutti, E.3
Severino, B.4
Fiorentina, R.5
Baldoni, M.6
Caliendo, G.7
-
59
-
-
38649117295
-
Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis
-
17962354 10.1152/ajpgi.00444.2007 1:CAS:528:DC%2BD1cXhtVWrt78%3D
-
Rullier A, Gillibert-Duplantier J, Costet P, Cubel G, Haurie V, Petibois C, Taras D, et al. Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2008;294:G226-235
-
(2008)
Am J Physiol Gastrointest Liver Physiol
, vol.294
-
-
Rullier, A.1
Gillibert-Duplantier, J.2
Costet, P.3
Cubel, G.4
Haurie, V.5
Petibois, C.6
Taras, D.7
-
60
-
-
49849095609
-
Effect of a thrombin receptor (protease-activated receptor 1, PAR-1) gene polymorphism in chronic hepatitis C liver fibrosis
-
18005014 10.1111/j.1440-1746.2007.05220.x 1:CAS:528:DC%2BD1cXht1Cls7nO
-
Martinelli A, Knapp S, Anstee Q, Worku M, Tommasi A, Zucoloto S, Goldin R, et al. Effect of a thrombin receptor (protease-activated receptor 1, PAR-1) gene polymorphism in chronic hepatitis C liver fibrosis. J Gastroenterol Hepatol 2008;23:1403-1409
-
(2008)
J Gastroenterol Hepatol
, vol.23
, pp. 1403-1409
-
-
Martinelli, A.1
Knapp, S.2
Anstee, Q.3
Worku, M.4
Tommasi, A.5
Zucoloto, S.6
Goldin, R.7
-
61
-
-
0033665744
-
The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985
-
11076885 10.1136/gut.47.6.845 1:STN:280:DC%2BD3M%2FmsVGjtw%3D%3D
-
Yee TT, Griffioen A, Sabin CA, Dusheiko G, Lee CA. The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. Gut 2000;47:845-851
-
(2000)
Gut
, vol.47
, pp. 845-851
-
-
Yee, T.T.1
Griffioen, A.2
Sabin, C.A.3
Dusheiko, G.4
Lee, C.A.5
-
62
-
-
34547615744
-
Are chronic hepatitis C viral infections more benign in patients with hemophilia?
-
17433021 10.1111/j.1572-0241.2007.01223.x 1:CAS:528:DC%2BD2sXhtVemsLrM
-
Assy N, Pettigrew N, Lee SS, Chaudhary RK, Johnston J, Minuk GY. Are chronic hepatitis C viral infections more benign in patients with hemophilia? Am J Gastroenterol 2007;102:1672-1676
-
(2007)
Am J Gastroenterol
, vol.102
, pp. 1672-1676
-
-
Assy, N.1
Pettigrew, N.2
Lee, S.S.3
Chaudhary, R.K.4
Johnston, J.5
Minuk, G.Y.6
-
63
-
-
0038637369
-
Factor v Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection
-
12865283 10.1136/gut.52.8.1206 1:STN:280:DC%2BD3szlsVWhsw%3D%3D
-
Wright M, Goldin R, Hellier S, Knapp S, Frodsham A, Hennig B, Hill A, et al. Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection. Gut 2003;52:1206-1210
-
(2003)
Gut
, vol.52
, pp. 1206-1210
-
-
Wright, M.1
Goldin, R.2
Hellier, S.3
Knapp, S.4
Frodsham, A.5
Hennig, B.6
Hill, A.7
-
64
-
-
83155165375
-
Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation
-
22174551 10.3748/wjg.v17.i45.5007 1:CAS:528:DC%2BC38Xpt10%3D
-
Maharshak N, Halfon P, Deutsch V, Peretz H, Berliner S, Fishman S, Zelber-Sagi S, et al. Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation. World J Gastroenterol 2011;17:5007-5013
-
(2011)
World J Gastroenterol
, vol.17
, pp. 5007-5013
-
-
Maharshak, N.1
Halfon, P.2
Deutsch, V.3
Peretz, H.4
Berliner, S.5
Fishman, S.6
Zelber-Sagi, S.7
-
65
-
-
0037369783
-
Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis
-
12584224 10.1136/gut.52.3.404 1:STN:280:DC%2BD3s%2FntlCguw%3D%3D
-
Papatheodoridis GV, Papakonstantinou E, Andrioti E, Cholongitas E, Petraki K, Kontopoulou I, Hadziyannis SJ. Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis. Gut 2003;52:404-409
-
(2003)
Gut
, vol.52
, pp. 404-409
-
-
Papatheodoridis, G.V.1
Papakonstantinou, E.2
Andrioti, E.3
Cholongitas, E.4
Petraki, K.5
Kontopoulou, I.6
Hadziyannis, S.J.7
-
66
-
-
1942536463
-
Genetic and acquired thrombotic factors in chronic hepatitis C
-
15056097 10.1111/j.1572-0241.2004.04092.x
-
Poujol-Robert A, Rosmorduc O, Serfaty L, Coulet F, Poupon R, Robert A. Genetic and acquired thrombotic factors in chronic hepatitis C. Am J Gastroenterol 2004;99:527-531
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 527-531
-
-
Poujol-Robert, A.1
Rosmorduc, O.2
Serfaty, L.3
Coulet, F.4
Poupon, R.5
Robert, A.6
-
67
-
-
33748607220
-
Association between ABO blood group and fibrosis severity in chronic hepatitis C infection
-
16927132 10.1007/s10620-006-9121-5
-
Poujol-Robert A, Boelle PY, Wendum D, Poupon R, Robert A. Association between ABO blood group and fibrosis severity in chronic hepatitis C infection. Dig Dis Sci 2006;51:1633-1636
-
(2006)
Dig Dis Sci
, vol.51
, pp. 1633-1636
-
-
Poujol-Robert, A.1
Boelle, P.Y.2
Wendum, D.3
Poupon, R.4
Robert, A.5
-
68
-
-
70349732866
-
Thrombotic risk factors and liver histologic lesions in nonalcoholic fatty liver disease
-
19726097 10.1016/j.jhep.2009.06.023 1:CAS:528:DC%2BD1MXht1CqurvO
-
Papatheodoridis GV, Chrysanthos N, Cholongitas E, Pavlou E, Apergis G, Tiniakos DG, Andrioti E, et al. Thrombotic risk factors and liver histologic lesions in nonalcoholic fatty liver disease. J Hepatol 2009;51:931-938
-
(2009)
J Hepatol
, vol.51
, pp. 931-938
-
-
Papatheodoridis, G.V.1
Chrysanthos, N.2
Cholongitas, E.3
Pavlou, E.4
Apergis, G.5
Tiniakos, D.G.6
Andrioti, E.7
-
69
-
-
7044284909
-
A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat
-
15519536 10.1016/j.phrs.2004.04.009 1:CAS:528:DC%2BD2cXpt1Wjtbo%3D
-
Abdel-Salam OM, Baiuomy AR, Ameen A, Hassan NS. A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat. Pharmacol Res 2005;51:59-67
-
(2005)
Pharmacol Res
, vol.51
, pp. 59-67
-
-
Abdel-Salam, O.M.1
Baiuomy, A.R.2
Ameen, A.3
Hassan, N.S.4
-
70
-
-
33845677618
-
Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat
-
17166617 10.1016/j.jhep.2006.08.023 1:CAS:528:DC%2BD2sXhslyltg%3D%3D
-
Abe W, Ikejima K, Lang T, Okumura K, Enomoto N, Kitamura T, Takei Y, et al. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat. J Hepatol 2007;46:286-294
-
(2007)
J Hepatol
, vol.46
, pp. 286-294
-
-
Abe, W.1
Ikejima, K.2
Lang, T.3
Okumura, K.4
Enomoto, N.5
Kitamura, T.6
Takei, Y.7
-
71
-
-
34247258487
-
The beneficial effect of aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of cirrhosis
-
17372820 10.1007/s10620-006-9595-1 1:CAS:528:DC%2BD2sXktlWitrk%3D
-
Assy N, Hussein O, Khalil A, Luder A, Szvalb S, Paizi M, Spira G. The beneficial effect of aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of cirrhosis. Dig Dis Sci 2007;52:1187-1193
-
(2007)
Dig Dis Sci
, vol.52
, pp. 1187-1193
-
-
Assy, N.1
Hussein, O.2
Khalil, A.3
Luder, A.4
Szvalb, S.5
Paizi, M.6
Spira, G.7
-
72
-
-
7244229502
-
A role for thrombin in liver fibrosis
-
15479692 10.1136/gut.2003.032136 1:CAS:528:DC%2BD2cXhtVajtrvF
-
Duplantier JG, Dubuisson L, Senant N, Freyburger G, Laurendeau I, Herbert JM, Desmouliere A, et al. A role for thrombin in liver fibrosis. Gut 2004;53:1682-1687
-
(2004)
Gut
, vol.53
, pp. 1682-1687
-
-
Duplantier, J.G.1
Dubuisson, L.2
Senant, N.3
Freyburger, G.4
Laurendeau, I.5
Herbert, J.M.6
Desmouliere, A.7
-
73
-
-
47649093322
-
Coagulation status modulates murine hepatic fibrogenesis: Implications for the development of novel therapies
-
18485088 10.1111/j.1538-7836.2008.03015.x 1:CAS:528:DC%2BD1cXhtVOgtbzM
-
Anstee QM, Goldin RD, Wright M, Martinelli A, Cox R, Thursz MR. Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies. J Thromb Haemost 2008;6:1336-1343
-
(2008)
J Thromb Haemost
, vol.6
, pp. 1336-1343
-
-
Anstee, Q.M.1
Goldin, R.D.2
Wright, M.3
Martinelli, A.4
Cox, R.5
Thursz, M.R.6
-
74
-
-
0043066540
-
Effects of heparin on liver fibrosis in patients with chronic hepatitis B
-
12854176 1:CAS:528:DC%2BD3sXoslajuro%3D
-
Shi J, Hao JH, Ren WH, Zhu JR. Effects of heparin on liver fibrosis in patients with chronic hepatitis B. World J Gastroenterol 2003;9:1611-1614
-
(2003)
World J Gastroenterol
, vol.9
, pp. 1611-1614
-
-
Shi, J.1
Hao, J.H.2
Ren, W.H.3
Zhu, J.R.4
-
75
-
-
84868148319
-
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis
-
Villa E, Camma C, Marietta M, Luongo M, Critelli R, Colopi S, Tata C, et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology 2012;143(1253-1260):e1254
-
(2012)
Gastroenterology
, vol.143
, Issue.1253-1260
, pp. 1254
-
-
Villa, E.1
Camma, C.2
Marietta, M.3
Luongo, M.4
Critelli, R.5
Colopi, S.6
Tata, C.7
|